Zeneca/SB Research Center Set Up
Two UK drug companies, Zeneca Pharmaceuticals and SmithKline Beecham, have agreed to establish the Zeneca/SmithKline Beecham Centre for Analytical Chemistry, which will be based at Imperial College, London.
Funding is being provided by the two companies for the SmithKline Beecham Chair in Analytical Chemistry and the Zeneca Lectureship in Analytical Chemistry. An additional lecturer and staff will be funded by the Department of Chemistry at Imperial College, and research students will be recruited to start in September/October 1995.
The Centre will: concentrate on the theoretical understanding of analytical science; provide problem-solving expertise; focus on analytical problems of particular relevance to the pharmaceutical industry; and increase the fundamental understanding of separation science as a major goal.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze